HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 76 filers reported holding HUMACYTE INC in Q4 2022. The put-call ratio across all filers is 1.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $457,488 | +224.5% | 95,310 | +110.3% | 0.00% | – |
| Q1 2024 | $140,976 | +9.5% | 45,330 | 0.0% | 0.00% | – |
| Q4 2023 | $128,737 | -3.1% | 45,330 | 0.0% | 0.00% | – |
| Q3 2023 | $132,817 | +24.4% | 45,330 | +21.4% | 0.00% | – |
| Q2 2023 | $106,764 | +93.0% | 37,330 | +108.5% | 0.00% | – |
| Q1 2023 | $55,311 | +69.1% | 17,900 | +15.5% | 0.00% | – |
| Q4 2022 | $32,705 | – | 15,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Endowment Wealth Management, Inc. | 100,518 | $482,486 | 0.35% |
| Monashee Investment Management LLC | 280,000 | $1,344,000 | 0.17% |
| United Asset Strategies, Inc. | 218,308 | $1,047,878 | 0.10% |
| HAMILTON LANE ADVISORS LLC | 21,893 | $105,086 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 224,179 | $1,076 | 0.08% |
| David J Yvars Group | 22,750 | $109,200 | 0.07% |
| ARS Investment Partners, LLC | 116,419 | $558,811 | 0.05% |
| EntryPoint Capital, LLC | 5,180 | $24,864 | 0.04% |
| Virtu Financial LLC | 103,163 | $495 | 0.04% |
| Anson Funds Management LP | 50,000 | $240,000 | 0.03% |